FDA to Cut Back Hiring of Non-US Citizens

The move appears to be out of step with other HHS agencies.

Written byShawna Williams
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

FDA building with signFDAHiring managers at the US Food and Drug Administration (FDA) will soon be unable to extend offers to non-citizens who have lived in the United States for fewer than three of the past five years, reports STAT. The policy, attributed to changes in the background check procedures needed to procure a government employee ID card, does not appear to be in line with policies at other federal science agencies, STAT finds.

A government policy on the ID cards, implemented in 2008, stipulates that applicants must have lived in the country for at least three of the preceding five years in order to complete the background check—but it also suggests that those who do not meet the requirement can be hired and use a different type of card until eligible.

An FDA document obtained by STAT states that the agency’s hiring change is due to a January 2017 update to that policy. Yet, “an HHS spokesman said the internal document did not include new policies on a residency requirement,” the outlet reports.

The order, expected to take effect October 1, will not apply to current employees. Nevertheless, two FDA staffers tell STAT they were “dismayed” and “stunned” ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • Shawna was an editor at The Scientist from 2017 through 2022. She holds a bachelor’s degree in biochemistry from Colorado College and a graduate certificate in science communication from the University of California, Santa Cruz. Previously, she worked as a freelance editor and writer, and in the communications offices of several academic research institutions. As news director, Shawna assigned and edited news, opinion, and in-depth feature articles for the website on all aspects of the life sciences. She is based in central Washington State, and is a member of the Northwest Science Writers Association and the National Association of Science Writers.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies